Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repeated Transcranial Magnetic Stimulation for the Treatment of Post-COVID Associated Affective Symptoms

NCT06716996 is registered in ClinicalTrials.gov with Flurin Cathomas as lead sponsor.

NCT NCT06716996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06716996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repeated Transcranial Magnetic Stimulation for the Treatment of Post-COVID Associated Affective Symptoms
Lead sponsor
Flurin Cathomas
Phase
Not applicable
Overall status
Recruiting
Start date
November 14, 2024
Completion date
October 31, 2028
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post covid -19 depression